001     138479
005     20240321220440.0
024 7 _ |a 10.1371/journal.pone.0151997
|2 doi
024 7 _ |a pmid:27055262
|2 pmid
024 7 _ |a pmc:PMC4824446
|2 pmc
024 7 _ |a altmetric:6557344
|2 altmetric
037 _ _ |a DZNE-2020-04801
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Van Uem, Janet M T
|0 P:(DE-2719)9000322
|b 0
|e First author
|u dzne
245 _ _ |a Quantitative Timed-Up-and-Go Parameters in Relation to Cognitive Parameters and Health-Related Quality of Life in Mild-to-Moderate Parkinson's Disease.
260 _ _ |a San Francisco, California, US
|c 2016
|b PLOS
264 _ 1 |3 online
|2 Crossref
|b Public Library of Science (PLoS)
|c 2016-04-07
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1604653411_15311
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a The instrumented-Timed-Up-and-Go test (iTUG) provides detailed information about the following movement patterns: sit-to-walk (siwa), straight walking, turning and walk-to-sit (wasi). We were interested in the relative contributions of respective iTUG sub-phases to specific clinical deficits most relevant for daily life in Parkinson’s disease (PD). More specifically, we investigated which condition–fast speed (FS) or convenient speed (CS)–differentiates best between mild- to moderate-stage PD patients and controls, which parameters of the iTUG sub-phases are significantly different between PD patients and controls, and how the iTUG parameters associate with cognitive parameters (with particular focus on cognitive flexibility and working memory) and Health-Related-Quality of Life (HRQoL).MethodsTwenty-eight PD participants (65.1±7.1 years, H&Y stage 1–3, medication OFF state) and 20 controls (66.1±7.5 years) performed an iTUG (DynaPort®, McRoberts BV, The Netherlands) under CS and FS conditions. The PD Questionnaire 39 (PDQ-39) was employed to assess HRQoL. General cognitive and executive functions were assessed using the Montreal Cognitive Assessment and the Trail Making Test.ResultsThe total iTUG duration and sub-phases durations under FS condition differentiated PD patients slightly better from controls, compared to the CS condition. The following sub-phases were responsible for the observed longer total duration PD patients needed to perform the iTUG: siwa, turn and wasi. None of the iTUG parameters correlated relevantly with general cognitive function. Turning duration and wasi maximum flexion velocity correlated strongest with executive function. Walking back duration correlated strongest with HRQoL.DiscussionThis study confirms that mild- to moderate-stage PD patients need more time to perform the iTUG than controls, and adds the following aspects to current literature: FS may be more powerful than CS to delineate subtle movement deficits in mild- to moderate-stage PD patients; correlation levels of intra-individual siwa and wasi parameters may be interesting surrogate markers for the level of automaticity of performed movements; and sub-phases and kinematic parameters of the iTUG may have the potential to reflect executive functioning and HRQoL aspects of PD patients.
536 _ _ |a 345 - Population Studies and Genetics (POF3-345)
|0 G:(DE-HGF)POF3-345
|c POF3-345
|f POF III
|x 0
536 _ _ |a 344 - Clinical and Health Care Research (POF3-344)
|0 G:(DE-HGF)POF3-344
|c POF3-344
|f POF III
|x 1
542 _ _ |i 2016-04-07
|2 Crossref
|u http://creativecommons.org/licenses/by/4.0/
588 _ _ |a Dataset connected to CrossRef, PubMed,
650 _ 2 |a Aged
|2 MeSH
650 _ 2 |a Algorithms
|2 MeSH
650 _ 2 |a Biomechanical Phenomena
|2 MeSH
650 _ 2 |a Case-Control Studies
|2 MeSH
650 _ 2 |a Cognition
|2 MeSH
650 _ 2 |a Cross-Sectional Studies
|2 MeSH
650 _ 2 |a Female
|2 MeSH
650 _ 2 |a Gait Disorders, Neurologic: physiopathology
|2 MeSH
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Male
|2 MeSH
650 _ 2 |a Middle Aged
|2 MeSH
650 _ 2 |a Netherlands
|2 MeSH
650 _ 2 |a Parkinson Disease: physiopathology
|2 MeSH
650 _ 2 |a Postural Balance
|2 MeSH
650 _ 2 |a Prospective Studies
|2 MeSH
650 _ 2 |a Quality of Life
|2 MeSH
650 _ 2 |a Time Factors
|2 MeSH
700 1 _ |a Walgaard, Stefan
|b 1
700 1 _ |a Ainsworth, Erik
|b 2
700 1 _ |a Hasmann, Sandra E
|0 P:(DE-2719)9000118
|b 3
|u dzne
700 1 _ |a Heger, Tanja
|0 P:(DE-2719)9000123
|b 4
|u dzne
700 1 _ |a Nußbaum, Susanne
|0 P:(DE-2719)2810733
|b 5
|u dzne
700 1 _ |a Hobert, Markus A
|0 P:(DE-2719)9000133
|b 6
|u dzne
700 1 _ |a Micó-Amigo, Encarnación M
|b 7
700 1 _ |a Van Lummel, Rob C
|b 8
700 1 _ |a Berg, Daniela
|0 P:(DE-2719)2000059
|b 9
|u dzne
700 1 _ |a Maetzler, Walter
|0 P:(DE-2719)2810915
|b 10
|e Last author
|u dzne
773 1 8 |a 10.1371/journal.pone.0151997
|b : Public Library of Science (PLoS), 2016-04-07
|n 4
|p e0151997
|3 journal-article
|2 Crossref
|t PLOS ONE
|v 11
|y 2016
|x 1932-6203
773 _ _ |a 10.1371/journal.pone.0151997
|g Vol. 11, no. 4, p. e0151997 -
|0 PERI:(DE-600)2267670-3
|n 4
|q 11:4|p e0151997
|t PLOS ONE
|v 11
|y 2016
|x 1932-6203
856 4 _ |u https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0151997
856 7 _ |2 Pubmed Central
|u http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4824446
856 4 _ |u https://pub.dzne.de/record/138479/files/4553.PDF
|y OpenAccess
856 4 _ |u https://pub.dzne.de/record/138479/files/4553.gif?subformat=icon
|x icon
|y OpenAccess
856 4 _ |u https://pub.dzne.de/record/138479/files/4553.jpg?subformat=icon-1440
|x icon-1440
|y OpenAccess
856 4 _ |u https://pub.dzne.de/record/138479/files/4553.jpg?subformat=icon-180
|x icon-180
|y OpenAccess
856 4 _ |u https://pub.dzne.de/record/138479/files/4553.jpg?subformat=icon-640
|x icon-640
|y OpenAccess
909 C O |o oai:pub.dzne.de:138479
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 0
|6 P:(DE-2719)9000322
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 3
|6 P:(DE-2719)9000118
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 4
|6 P:(DE-2719)9000123
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 5
|6 P:(DE-2719)2810733
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 6
|6 P:(DE-2719)9000133
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 9
|6 P:(DE-2719)2000059
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 10
|6 P:(DE-2719)2810915
913 1 _ |a DE-HGF
|b Forschungsbereich Gesundheit
|l Erkrankungen des Nervensystems
|1 G:(DE-HGF)POF3-340
|0 G:(DE-HGF)POF3-345
|2 G:(DE-HGF)POF3-300
|v Population Studies and Genetics
|x 0
913 1 _ |a DE-HGF
|b Forschungsbereich Gesundheit
|l Erkrankungen des Nervensystems
|1 G:(DE-HGF)POF3-340
|0 G:(DE-HGF)POF3-344
|2 G:(DE-HGF)POF3-300
|v Clinical and Health Care Research
|x 1
914 1 _ |y 2016
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a Creative Commons Attribution CC BY (No Version)
|0 LIC:(DE-HGF)CCBYNV
|2 V:(DE-HGF)
|b DOAJ
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1040
|2 StatID
|b Zoological Record
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b PLOS ONE : 2017
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
920 1 _ |0 I:(DE-2719)5000024
|k AG Maetzler
|l Functional Neurogeriatrics
|x 0
920 1 _ |0 I:(DE-2719)5000055
|k AG Berg
|l Parkinson's Disease Genetics AG Berg
|x 1
920 1 _ |0 I:(DE-2719)5000056
|k Ext UKT-Trend
|l Ext UKT TREND Studie
|x 2
920 1 _ |0 I:(DE-2719)1210000
|k AG Gasser
|l Parkinson Genetics
|x 3
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-2719)5000024
980 _ _ |a I:(DE-2719)5000055
980 _ _ |a I:(DE-2719)5000056
980 _ _ |a I:(DE-2719)1210000-7
980 1 _ |a FullTexts
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.parkreldis.2010.08.012
|2 Crossref
|o 10.1016/j.parkreldis.2010.08.012
999 C 5 |9 -- missing cx lookup --
|a 10.1016/S0895-4356(98)00179-6
|2 Crossref
|o 10.1016/S0895-4356(98)00179-6
999 C 5 |2 Crossref
|o JMT van Uem
999 C 5 |2 Crossref
|o
999 C 5 |9 -- missing cx lookup --
|a 10.1007/s00415-005-0855-3
|2 Crossref
|o 10.1007/s00415-005-0855-3
999 C 5 |y 2001
|2 Crossref
|o S Morris 2001
999 C 5 |9 -- missing cx lookup --
|a 10.1007/s11136-012-0289-1
|2 Crossref
|o 10.1007/s11136-012-0289-1
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.medengphy.2009.10.015
|2 Crossref
|o 10.1016/j.medengphy.2009.10.015
999 C 5 |9 -- missing cx lookup --
|a 10.1109/TNSRE.2010.2047606
|2 Crossref
|o 10.1109/TNSRE.2010.2047606
999 C 5 |9 -- missing cx lookup --
|a 10.1002/ana.22165
|2 Crossref
|o 10.1002/ana.22165
999 C 5 |9 -- missing cx lookup --
|a 10.1371/journal.pone.0032240
|2 Crossref
|o 10.1371/journal.pone.0032240
999 C 5 |9 -- missing cx lookup --
|a 10.3389/fnagi.2014.00286
|2 Crossref
|o 10.3389/fnagi.2014.00286
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.gaitpost.2012.04.010
|2 Crossref
|o 10.1016/j.gaitpost.2012.04.010
999 C 5 |9 -- missing cx lookup --
|a 10.1002/mds.25682
|2 Crossref
|o 10.1002/mds.25682
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.gaitpost.2013.11.021
|2 Crossref
|o 10.1016/j.gaitpost.2013.11.021
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.apmr.2013.10.031
|2 Crossref
|o 10.1016/j.apmr.2013.10.031
999 C 5 |9 -- missing cx lookup --
|a 10.1212/01.wnl.0000338632.00552.cb
|2 Crossref
|o 10.1212/01.wnl.0000338632.00552.cb
999 C 5 |y 2015
|2 Crossref
|o VE Kelly 2015
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.jocn.2014.11.030
|2 Crossref
|o 10.1016/j.jocn.2014.11.030
999 C 5 |9 -- missing cx lookup --
|a 10.1002/mds.26051
|2 Crossref
|o 10.1002/mds.26051
999 C 5 |y 1967
|2 Crossref
|o NA Bernstein 1967
999 C 5 |9 -- missing cx lookup --
|a 10.1093/brain/awh569
|2 Crossref
|o 10.1093/brain/awh569
999 C 5 |y 1975
|2 Crossref
|o MF Folstein 1975
999 C 5 |9 -- missing cx lookup --
|a 10.1002/mds.21198
|2 Crossref
|o 10.1002/mds.21198
999 C 5 |9 -- missing cx lookup --
|a 10.1212/WNL.40.10.1529
|2 Crossref
|o 10.1212/WNL.40.10.1529
999 C 5 |9 -- missing cx lookup --
|a 10.1002/mds.22017
|2 Crossref
|o 10.1002/mds.22017
999 C 5 |9 -- missing cx lookup --
|a 10.1016/S0887-6177(03)00039-8
|2 Crossref
|o 10.1016/S0887-6177(03)00039-8
999 C 5 |9 -- missing cx lookup --
|a 10.1371/journal.pone.0027831
|2 Crossref
|o 10.1371/journal.pone.0027831
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.jns.2014.07.026
|2 Crossref
|o 10.1016/j.jns.2014.07.026
999 C 5 |9 -- missing cx lookup --
|a 10.1590/S0004-282X2012000200009
|2 Crossref
|o 10.1590/S0004-282X2012000200009
999 C 5 |9 -- missing cx lookup --
|a 10.1007/PL00007730
|2 Crossref
|o 10.1007/PL00007730
999 C 5 |y 1998
|2 Crossref
|o C Jenkinson 1998
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.parkreldis.2011.07.004
|2 Crossref
|o 10.1016/j.parkreldis.2011.07.004
999 C 5 |9 -- missing cx lookup --
|a 10.1371/journal.pone.0086262
|2 Crossref
|o 10.1371/journal.pone.0086262
999 C 5 |9 -- missing cx lookup --
|a 10.1007/BF02345283
|2 Crossref
|o 10.1007/BF02345283
999 C 5 |2 Crossref
|o S Walgaard
999 C 5 |y 2014
|2 Crossref
|o T Wu 2014
999 C 5 |y 2004
|2 Crossref
|o C Dancey 2004
999 C 5 |9 -- missing cx lookup --
|a 10.1007/s00702-013-1051-8
|2 Crossref
|o 10.1007/s00702-013-1051-8
999 C 5 |9 -- missing cx lookup --
|a 10.1002/mds.24973
|2 Crossref
|o 10.1002/mds.24973
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.clinbiomech.2012.09.005
|2 Crossref
|o 10.1016/j.clinbiomech.2012.09.005
999 C 5 |9 -- missing cx lookup --
|a 10.1002/mds.22079
|2 Crossref
|o 10.1002/mds.22079
999 C 5 |9 -- missing cx lookup --
|a 10.1093/brain/110.2.361
|2 Crossref
|o 10.1093/brain/110.2.361
999 C 5 |9 -- missing cx lookup --
|a 10.1093/brain/115.5.1481
|2 Crossref
|o 10.1093/brain/115.5.1481
999 C 5 |9 -- missing cx lookup --
|a 10.1371/journal.pone.0093572
|2 Crossref
|o 10.1371/journal.pone.0093572
999 C 5 |9 -- missing cx lookup --
|a 10.1080/09638280701829938
|2 Crossref
|o 10.1080/09638280701829938
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.gaitpost.2006.05.013
|2 Crossref
|o 10.1016/j.gaitpost.2006.05.013
999 C 5 |9 -- missing cx lookup --
|a 10.1016/S0268-0033(01)00035-3
|2 Crossref
|o 10.1016/S0268-0033(01)00035-3
999 C 5 |9 -- missing cx lookup --
|a 10.1002/mds.25285
|2 Crossref
|o 10.1002/mds.25285
999 C 5 |9 -- missing cx lookup --
|a 10.1007/s00221-007-0955-7
|2 Crossref
|o 10.1007/s00221-007-0955-7
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.gaitpost.2007.04.010
|2 Crossref
|o 10.1016/j.gaitpost.2007.04.010
999 C 5 |9 -- missing cx lookup --
|a 10.1002/mds.21943
|2 Crossref
|o 10.1002/mds.21943
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.expneurol.2009.06.013
|2 Crossref
|o 10.1016/j.expneurol.2009.06.013
999 C 5 |9 -- missing cx lookup --
|a 10.1016/S0304-3940(98)00625-9
|2 Crossref
|o 10.1016/S0304-3940(98)00625-9
999 C 5 |9 -- missing cx lookup --
|a 10.1007/s00221-005-2346-2
|2 Crossref
|o 10.1007/s00221-005-2346-2
999 C 5 |9 -- missing cx lookup --
|a 10.1007/s004150050265
|2 Crossref
|o 10.1007/s004150050265
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.nbd.2015.06.014
|2 Crossref
|o 10.1016/j.nbd.2015.06.014
999 C 5 |y 2015
|2 Crossref
|o HF Kim 2015
999 C 5 |9 -- missing cx lookup --
|a 10.3758/BF03196201
|2 Crossref
|o 10.3758/BF03196201
999 C 5 |9 -- missing cx lookup --
|a 10.1037/0096-3445.130.4.701
|2 Crossref
|o 10.1037/0096-3445.130.4.701
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.archger.2012.06.002
|2 Crossref
|o 10.1016/j.archger.2012.06.002
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.parkreldis.2012.06.010
|2 Crossref
|o 10.1016/j.parkreldis.2012.06.010
999 C 5 |9 -- missing cx lookup --
|a 10.3233/JPD-130321
|2 Crossref
|o 10.3233/JPD-130321
999 C 5 |9 -- missing cx lookup --
|a 10.3233/JPD-130181
|2 Crossref
|o 10.3233/JPD-130181
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.neuroimage.2009.10.051
|2 Crossref
|o 10.1016/j.neuroimage.2009.10.051
999 C 5 |9 -- missing cx lookup --
|a 10.1002/mds.22789
|2 Crossref
|o 10.1002/mds.22789
999 C 5 |9 -- missing cx lookup --
|a 10.1002/mds.21853
|2 Crossref
|o 10.1002/mds.21853
999 C 5 |9 -- missing cx lookup --
|a 10.1212/01.wnl.0000313835.33830.80
|2 Crossref
|o 10.1212/01.wnl.0000313835.33830.80
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.neubiorev.2015.11.014
|2 Crossref
|o 10.1016/j.neubiorev.2015.11.014
999 C 5 |9 -- missing cx lookup --
|a 10.1002/mds.24893
|2 Crossref
|o 10.1002/mds.24893
999 C 5 |y 1998
|2 Crossref
|o D CAHN 1998
999 C 5 |9 -- missing cx lookup --
|a 10.1080/13803395.2013.798397
|2 Crossref
|o 10.1080/13803395.2013.798397


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21